9 , 29 , 30 , 31 In observational studies based on European and American study populations, however, the reported rates of discontinuation and addon therapy were much higher than reported in the randomized clinical trials
This is because the FDA has noted that the current data isnt enough to fully understand the potential risks
FDA has warned that companies should not claim compounded GLP-1 drugs are FDA-approved generics or clinically proven equivalents
A notes app on your phone, a paper calendar near your supplies, a medication tracking app, or even a simple sticky note rotation chartall work
Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
You will probably swallow too soon at least once